[{"from": "human", "value": "Describe this molecule. [C][C][C][C][C][C][C][C][C][C][C][C][C][C][=Branch1][C][=O][O][C][C@H1][Branch2][O][Ring2][C][O][C@H1][C@@H1][Branch2][#Branch2][N][C@H1][Branch2][#Branch2][#Branch1][C@@H1][Branch2][#Branch2][C][C@H1][Branch1][Ring2][O][Ring1][=Branch1][C][O][C@H1][C@@H1][Branch2][=Branch2][Ring2][C@H1][Branch2][Branch2][#C][C@@H1][Branch2][Branch2][#Branch2][C@H1][Branch1][Ring2][O][Ring1][=Branch1][C][O][C@H1][C@@H1][Branch2][#Branch1][N][C@H1][Branch2][#Branch1][#Branch1][C@@H1][Branch2][#Branch1][C][C@H1][Branch1][Ring2][O][Ring1][=Branch1][C][O][P][=Branch1][C][=O][Branch1][C][O][O][C][C@@H1][C@H1][Branch2][Branch1][O][C@@H1][Branch2][Ring1][N][C@H1][Branch2][Ring1][C][C@H1][Branch1][Ring2][O][Ring1][=Branch1][O][C@H1][Branch1][Ring1][C][O][C][=Branch1][C][=O][O][N][C][=Branch1][C][=O][C][O][C@@H1][C@@H1][Branch1][P][C@H1][Branch1][=N][C@@H1][Branch1][=Branch2][C@H1][Branch1][Ring2][O][Ring1][=Branch1][C][O][O][O][N][C][=Branch1][C][=O][C][O][O][O][O][O][O][O][O][O][O][O][C][=Branch1][C][=O][C][C][C][C][C][C][C][C][C][C][C][C][C]"}, {"from": "gpt", "value": "The molecule is a glycosylglycerol derivative in which the glycosyl moiety of glycosyl-sn-glycerol is N-acetyl-beta-D-glucosaminyl-(1->3)-[(D-glyceric acid)-(2->1)]-beta-D-glucosaminyl-(6-phospho-6)-beta-D-glucosyl-(1->6)-beta-D-glucosyl-(1->6)-beta-D-glucosyl attached at O-3, with O-1 and O-2 both carrying myristoyl substituents. Synthetic C. difficile lipoteichoic acid (LTA) molecule consisting of lipid + core region and one [(->6)-alpha-D-GlcpNAc-(1->3)-[P-6]-alpha-D-GlcpNAc-(1->2)-D-GroA polymeric repeat (where P-6 is a phosphodiester bridge and GroA is glyceric acid). It is a glycosylglycerol derivative and a lipoteichoic acid. It is functionally related to a 1,2-ditetradecanoyl-sn-glycerol."}]